| Normal subjects (n = 30) | ESRD with targeted iPTH (n = 32) | ESRD with increased iPTH (n = 40) |
---|---|---|---|
LV function | Â | Â | Â |
 EF (%) | 65.0 ± 4.5 | 55.9 ± 12.0* | 51.7 ± 12.8* |
 EDV (mL) | 117 ± 31 | 128 ± 44 | 134 ± 50 |
 ESV (mL) | 45 ± 13 | 60 ± 44 | 69 ± 47* |
 SV (mL) | 79 ± 17 | 67 ± 18 | 65 ± 18 |
 LV mass (g) | 52 ± 17 | 85 ± 31* | 90 ± 32* |
 EDV/BSA (mL/mm2) | 72.3 ± 20.1 | 83.3 ± 26.4 | 84.8 ± 36.3 |
 ESV/BSA (mL/m2) | 260.0 ± 5.5 | 38.9 ± 26.4 | 43.8 ± 34.4 * |
 SV/BSA (mL/m2) | 48.6 ± 11.2 | 44.2 ± 11.6 | 40.3 ± 10.9* |
 Mass/BSA (g/m2) | 32.2 ± 11.4 | 54.4 ± 19.0* | 56.3 ± 19.0* |
Myocardial strain parameters | Â | Â | Â |
 PRS | 43.0 ± 9.8 | 43.2 ± 14.9 | 37.6 ± 15.7 |
 PCS | − 18.3 ± 2.1 | − 17.8 ± 4.2 | − 16.8 ± 5.0 |
 PLS | − 16.5 ± 2.4 | − 15.7 ± 3.7 | − 14.8 ± 4.4 |
Native T1 value | Â | Â | Â |
 Basal segment | 1238 ± 36 | 1304 ± 41* | 1330 ± 43*# |
 Middle segment | 1242 ± 50 | 1300 ± 43* | 1323 ± 43*# |
 Apical segment | 1280 ± 65 | 1339 ± 86 | 1360 ± 74* |
Global | 1251 ± 49 | 1305 ± 41* | 1334 ± 40*# |